The short version of synaptogenesis fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2025-07-24 and is reviewed periodically as new material appears.
Early laboratory work focused on its effects on synaptic connectivity and neuronal signaling. In cell and animal models, dihexa has been reported to promote the formation of new synapses, a process called synaptogenesis. These findings have generated interest in cognitive research, but the evidence base remains mostly preclinical. Human clinical trials with clear safety and efficacy endpoints are limited or absent in the public literature. Whether these effects translate to humans is an open question.
The proposed mechanism involves interaction with the hepatocyte growth factor (HGF) system and its receptor, c-Met. Dihexa is described in some studies as an HGF mimetic, meaning it may mimic or enhance HGF-mediated signaling. Activation of c-Met can influence cell growth, survival, and cytoskeletal remodeling, pathways that intersect with synaptic plasticity. However, the precise binding targets and downstream events for dihexa are not fully established, and alternative mechanisms have been suggested.
Dihexa appears in scientific literature, patent documents, and commercial catalogs under several names, which can complicate searching and verification. The compound is frequently grouped with nootropics or research chemicals, terms that describe context of use rather than regulatory approval. Such labeling may imply benefits that have not been confirmed in controlled human studies. Readers encountering promotional descriptions should distinguish between preclinical observations and established medical facts. The absence of regulatory approval is a central feature of its current status.
Dihexa is a synthetic peptide-like compound studied in preclinical research for its reported effects on synaptic growth and cognitive measures in animal models. It is often described as an analog of angiotensin IV, a naturally occurring peptide fragment. The compound has not been approved as a medicine in any major jurisdiction. Most public information comes from laboratory studies, patents, and online vendor listings rather than from large clinical trials. Its scientific status therefore differs from that of an established pharmaceutical.
| Property | Value | Notes |
|---|---|---|
| Chemical name | N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide | Common full name in research literature. |
| Class | Synthetic peptide | Modified angiotensin IV analog. |
| Related compound | Angiotensin IV | Parent peptide fragment. |
| Proposed target | HGF/c-Met pathway | Described as an HGF mimetic; not fully confirmed. |
| Development status | Preclinical research | No widely approved clinical use. |
Discussion in the literature often separates direct receptor activation from downstream growth-factor modulation. Dihexa is not simply an angiotensin receptor blocker or a classic nootropic drug. Its proposed action may depend on endogenous HGF levels, which vary by tissue and physiological state. Questions remain about brain penetration, metabolic stability, and active metabolites. Reviews note that mechanistic claims should be treated as hypotheses until supported by independent studies. That distinction is important when interpreting promotional claims or early laboratory findings.
The leading hypothesis for dihexa centers on hepatocyte growth factor (HGF) and its receptor, c-Met. In cell-based assays, dihexa has been reported to potentiate HGF-dependent signaling. That pathway influences cell growth, survival, and motility. Because c-Met signaling is widespread, the proposed mechanism is broad rather than specific to neurons. The exact binding site and stoichiometry remain areas of active investigation, and independent replication is limited. This uncertainty limits firm conclusions about how the compound acts in living organisms.
The compound originated from work on angiotensin IV, a peptide fragment of the renin-angiotensin system. Researchers modified angiotensin IV-related structures to produce molecules with altered stability and activity. Dihexa emerged from that effort and was reported to promote dendritic spine growth in cultured neurons. Some studies link its effects to hepatocyte growth factor signaling and the c-Met receptor, while other work points to insulin-regulated aminopeptidase. The precise primary target remains a subject of investigation, and findings may depend on cell type, assay conditions, and species.
In animal research, dihexa has been administered through several routes, and reports describe improved performance on spatial learning and memory tasks in rodents. These results are frequently cited in discussions of nootropic compounds. However, species differences, small sample sizes, and varied testing protocols limit how far the findings can be generalized. No large randomized controlled trials in humans have established efficacy or long-term safety. Claims about human cognitive enhancement therefore remain speculative, and the compound is best described as an experimental laboratory substance rather than a proven therapeutic or supplement.
Dihexa is a synthetic compound studied in laboratory and animal models for effects on synaptic connectivity and cognitive performance. It is often described as a peptide analog because its structure incorporates amino acid residues linked to a hexanoic acid group. The molecule is not a naturally occurring human hormone or neurotransmitter. Its name appears in research literature and online discussions, but it has not been approved as a medicine by major regulatory agencies. Most information comes from preclinical experiments rather than controlled human trials.
In laboratory settings, dihexa is typically handled as a lyophilized peptide powder. Appropriate personal protective equipment and a ventilated workspace are standard practices for weighing and transferring research chemicals. Because the compound lacks regulatory approval for clinical use, it should not be given to people. Institutional safety rules and local regulations govern its acquisition, storage, and disposal. Suppliers often provide a certificate of analysis that lists purity, identity, and batch-specific handling notes.
Dissolution depends on the peptide’s salt form, purity, and the chosen solvent. Dimethyl sulfoxide is commonly used to prepare concentrated stock solutions, while aqueous buffers may show limited solubility. Sonication or gentle warming can sometimes aid dissolution, but excessive heat may promote degradation. Once in solution, the material is generally kept cold and protected from light. Researchers should verify solubility for each lot rather than assuming uniform behavior across suppliers.
The two substrates of this enzyme are isoamyl alcohol (3-methylbutan-1-ol) and oxidised nicotinamide adenine dinucleotide (NAD+). Its products are isovaleraldehyde (3-methylbutanal), reduced NADH, and a proton. The enzyme can also use the alternative cofactor, nicotinamide adenine dinucleotide phosphate This enzyme belongs to the family of oxidoreductases, specifically those acting on the CH-OH group of donor with NAD+ or NADP+ as acceptor. The systematic name of this enzyme class is 3-methylbutanol:NAD(P)+ oxidoreductase.
The World Bank reports that, in 2007, electricity was largely supplied by local businesses. Among these domestic firms is the Somali Energy Company, which performs generation, transmission and distribution of electric power. In 2010, the nation produced 310 million kWh and consumed 288.3 million kWh of electricity, ranked 170th and 177th, respectively, according to the CIA.
On 8 March 2022, facing continued pressure due to the Russian invasion of Ukraine, McDonald's announced the temporary suspension of operation of its restaurants in Russia, while also announcing at the same time that it would continue to pay its employees in the country. The restaurants were taken over by the CEO of McDonald's Russia, Oleg Paroyev, and remained open as of mid-March 2022. On 16 May, the company decided to leave Russia altogether. On 27 May 2022, it was reported that McDonald's was selling its stores in Russia to a local licensee, Alexander Govor. Patent filings showed "Fun and Tasty" and "The Same One" as some of the possible brand names for the firm taking over McDonald's in Russia. Shortly after the announcement, the company replaced the McDonald's logo in favor of their own logo. The new name of the chain was later announced as Vkusno i tochka (Russian: Вкусно — и точка), translated as "Tasty, period". The legal entity remained the same but was renamed from McDonald's LLC to PBO System LLC, with Oleg Paroyev remaining as CEO. On 12 June, the restaurant chain reopened 15 restaurants in Moscow. The next day, the restaurant chain reopened 50 more restaurants in Moscow and the wider Moscow region. McDonald's has a 15-year option to buy its former restaurants back from Vkusno i tochka. On 8 July, RBK reported citing the company's press service that some restaurants would stop selling French fries and potato dishes due to a poor harvest the previous year, possibly until fall.
== Selected awards == US National Academy of Inventors, Elected Fellow, 2018 T. & A. Higuchi Memorial Lectureship Award, Academy of Pharmaceutical Science and Technology, Japan, 2018 Distinguished Mentor Award, University of Utah, 2017 Doctor of Philosophy honoris causa, University of Helsinki, Finland, 2014 US National Academy of Engineering, Member, 2011 Honorary professorship, Sichuan University, China, 2007 Distinguished International Scientist Award, Japanese Biomaterials Society, 2006 Chair, Gordon Research Conference on Drug Carriers in Medicine and Biology, 2004 J. Heyrovský Honorary Medal for Merit in the Chemical Sciences, Academy of Sciences of the Czech Republic, 2003 Paul Dawson Biotechnology Award, American Association of Colleges of Pharmacy, 2001 Millennial Pharmaceutical Scientist Award, Millennial World Congress of Pharm. Sciences, 2000 Fellow of Biomaterials Science and Engineering, International Union of Societies of Biomaterials Science and Engineering, 1999 Founders Award, Controlled Release Society, 1999 Czech Learned Society, Honorary Member, 1998 Award of the Presidia of the Czechoslovak and USSR Academies of Sciences 1977 Selected publications and patents
=== Domestic-level exposure === Radon has been considered the second leading cause of lung cancer in the United States and leading environmental cause of cancer mortality by the EPA, with the first one being smoking. Others have reached similar conclusions for the United Kingdom and France. Radon exposure in buildings may arise from subsurface rock formations and certain building materials (e.g., some granites). The greatest risk of radon exposure arises in buildings that are airtight, insufficiently ventilated, and have foundation leaks that allow air from the soil into basements and dwelling rooms. In some regions, such as Niška Banja, Serbia and in Ullensvang, Norway, outdoor radon concentrations may be exceptionally high, though compared to indoors, where people spend more time and air is not dispersed and exchanged as often, outdoor exposure to radon is not considered a significant health risk. Radon exposure (mostly radon daughters) has been linked to lung cancer in case-control studies performed in the US, Europe and China. There are approximately 21,000 deaths per year in the US (0.0063% of a population of 333 million) due to radon-induced lung cancers. In Europe, 2% of all cancers have been attributed to radon; in Slovenia in particular, a country with a high concentration of radon, about 120 people (0.0057% of a population of 2.11 million) die yearly because of radon. One of the most comprehensive radon studies performed in the US by epidemiologist R.
Sources: en.wikipedia.org
, which may allow to redefine the distributions as simple functions of the age only. If the flow is steady (but a generalization to non-steady flow is possible) and is conservative, then the exit age distribution and the internal age distribution can be related one to the other:
Has written for The Guardian London Review of Books, Red Pepper (magazine), Novara Media, Radical Philosophy, and has worked with Jews for Justice for Palestinians, Independent Jewish Voices and Faculty for Israeli–Palestinian Peace (FFIPP) engaged in efforts to end the Israeli occupation of Palestinian land and create a just peace between Israel and Palestine. Anthony Seldon (born 2 August 1953); educator, contemporary historian, journalist, broadcaster, academic, author, wrote biographies of British Prime Ministers, John Major, Tony Blair, Gordon Brown, David Cameron, Theresa May and Boris Johnson; was master (headmaster) of Wellington College, one of Britain's co-educational independent boarding schools, and is current Head Master of Epsom College; is author or editor of more than 45 books on contemporary history, politics and education; was co-founder and first director of Centre for Contemporary British History; co-founder of Action for Happiness, is a governor of the Royal Shakespeare Company, and is on board of a number of charities and educational bodies; is honorary historical adviser to 10 Downing Street and member of the First World War Centenary Culture Committee; was knighted in the 2014 Birthday Honours for services to education and modern political history.
Redness and swelling Induration (hardening of the skin and soft tissue) Excessive pain Systemic symptoms, including high fever > 102 °F/39 °C, fatigue, muscle pains Large amounts of smelly pus and discharge, especially at a surgical site The initial skin changes are similar to cellulitis or abscess, so diagnosis in early stages may be difficult. The redness and swelling usually blend into the surrounding normal tissues. The overlying skin may appear shiny and tense as well. Later signs more suggestive of necrotizing changes (but only present in less than half of cases) are:
=== Mechanical engineer === In 1912, Jones moved to Hallock, Minnesota, where he worked as a mechanic on a 50,000-acre (200 km2) farm. The farm was owned by James J. Hill, who was also owner of the Great Northern Railroad. Jones' proximity to Hill and the railroad facilitated his education in electricity and steam locomotive engines. Jones lived there for more than 20 years and would later say in a newspaper article that Hallock was a place "where a man … [was] judged more on his character and ability than on the color of his skin." He was locally known as "Casey" due to a remark by a railroad engineer he met while working at Hill Farm (see also Casey Jones). Jones received his engineering license at age 20. He later upgraded his license to the highest grade.
== Chemistry == Tofu is made from soy milk which is a turbid colloid liquid/solution. Tofu structure is related to soy milk components, particularly colloid components such as protein particles and oil globules. Protein particle content increases with the increase of the globulin ratio in the soybeans. Tofu varieties ensue from adding coagulants at various concentrations.
Sources: en.wikipedia.org
Dihexa is a synthetic peptide analog of angiotensin IV, often described as an HGF mimetic in research literature. It is studied for effects on synaptic connectivity in laboratory models. It is not an approved medication.
No, dihexa is a synthetic compound derived from the structure of angiotensin IV. Angiotensin IV occurs naturally, but dihexa has modifications that change its properties. It is not a standard dietary component.
The main hypothesis is that dihexa interacts with the hepatocyte growth factor system, possibly through c-Met signaling. This interaction may influence synaptogenesis and neuronal plasticity. The exact molecular target remains an active area of study.
Dihexa is a synthetic peptide-like compound studied in preclinical research. It is often described as an angiotensin IV analog, but it is not an approved medicine. Public information comes mainly from laboratory work and commercial listings.